Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS

E Tsourdi; B Langdahl; M Cohen-Solal; B Aubry-Rozier; EF Eriksen; N Guanabens; B Obermayer-Pietsch; SH Ralston; R Eastell; M.C. Zillikens

doi:10.1016/j.bone.2017.08.003

Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS

E Tsourdi, B Langdahl, M Cohen-Solal, B Aubry-Rozier, EF Eriksen, N Guanabens, B Obermayer-Pietsch, SH Ralston, R Eastell, M.C. Zillikens

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

387 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	11-17
Number of pages	7
Journal	Bone
Volume	105
DOIs	https://doi.org/10.1016/j.bone.2017.08.003
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1016/j.bone.2017.08.003

http://hdl.handle.net/1765/101410

Cite this

@article{dac8249989884f08aa9626bd74d679a0,

title = "Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS",

author = "E Tsourdi and B Langdahl and M Cohen-Solal and B Aubry-Rozier and EF Eriksen and N Guanabens and B Obermayer-Pietsch and SH Ralston and R Eastell and M.C. Zillikens",

year = "2017",

doi = "10.1016/j.bone.2017.08.003",

language = "Undefined/Unknown",

volume = "105",

pages = "11--17",

journal = "Bone",

issn = "8756-3282",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS

AU - Tsourdi, E

AU - Langdahl, B

AU - Cohen-Solal, M

AU - Aubry-Rozier, B

AU - Eriksen, EF

AU - Guanabens, N

AU - Obermayer-Pietsch, B

AU - Ralston, SH

AU - Eastell, R

AU - Zillikens, M.C.

PY - 2017

Y1 - 2017

U2 - 10.1016/j.bone.2017.08.003

DO - 10.1016/j.bone.2017.08.003

M3 - Article

C2 - 28789921

SN - 8756-3282

VL - 105

SP - 11

EP - 17

JO - Bone

JF - Bone

ER -